Efficacy of behavioural activation in the treatment of negative symptoms in people with schizophrenia spectrum disorders: A systematic review

Aboraya, 2016, Perspectives on the positive and negative syndrome scale (PANSS): use, misuse, drawbacks, and a new alternative for schizophrenia research, Ann. Clin. Psychiatry, 28, 125 Andreasen, 1989, The scale for the assessment of negative symptoms (SANS): conceptual and theoretical foundations, The Br. J. Psychiatry, 155, 49, 10.1192/S0007125000291496 Baker, 2019, Refining a model of collaborative care for people with a diagnosis of bipolar, schizophrenia or other psychoses in England: a qualitative formative evaluation, BMC Psychiatry, 19, 7, 10.1186/s12888-018-1997-z Bighelli, 2018, Psychological interventions to reduce positive symptoms in schizophrenia: systematic review and network meta-analysis, World Psychiatry, 17, 316, 10.1002/wps.20577 Bobes, 2010, Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study, J. Clin. Psychiatry, 71, 280, 10.4088/JCP.08m04250yel Bortolon, 2019, The contribution of optimism and hallucinations to grandiose delusions in individuals with schizophrenia, Schizophr. Res., 210, 203, 10.1016/j.schres.2018.12.037 Brożek, 2011, Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations, Allergy, 66, 588, 10.1111/j.1398-9995.2010.02530.x Charrois, 2015, Systematic reviews: what do you need to know to get started?, Can. J. Hosp. Pharm., 68, 144 Cheong, 1999, Development of Korean auditory verbal learning test, J. Korean Neuropsychiatric Assoc., 1016 Choi, 2014, Psychosocial approaches to negative symptoms of schizophrenia: a comprehensive systematic review Korean, J. Psychol. General, 33, 875 Choi, 2016, Motivational and behavioral activation as an adjunct to psychiatric rehabilitation for mild to moderate negative symptoms in individuals with schizophrenia: a proof-of-concept pilot study, Front. Psychol., 7, 1759, 10.3389/fpsyg.2016.01759 Chong, 2016, Global economic burden of schizophrenia: a systematic review, Neuropsychiatr. Dis. Treat., 12, 357 Demyttenaere, 2022, Disentangling the symptoms of schizophrenia: network analysis in acute phase patients and in patients with predominant negative symptoms, Eur. Psychiatry, 65, e18, 10.1192/j.eurpsy.2021.2241 de Pinho, 2018, Quality of life scale and symptomatology of schizophrenic patients – a systematic review, Eur. J. Psychiatry, 32, 1, 10.1016/j.ejpsy.2017.08.002 Ekers, 2011, Behavioural activation delivered by the non-specialist: phase II randomised controlled trial, Br. J. Psychiatry, 198, 66, 10.1192/bjp.bp.110.079111 Ekers, 2014, Behavioural activation for depression: an update of meta-analysis of effectiveness and sub group analysis, PLoS ONE, 9, 10.1371/journal.pone.0100100 Finning, 2017, Cost and outcome of behavioural activation versus cognitive behavioural therapy for depression (COBRA): a qualitative process evaluation, BMJ Open, 7, 10.1136/bmjopen-2016-014161 Hackenbroich, 2022, Include or not to include conference abstracts in systematic reviews? Lessons learned from a large Cochrane network meta-analysis including 585 trials, Syst. Rev., 11, 178, 10.1186/s13643-022-02048-6 Harvey, 2016, A Systematic review and network meta-analysis to assess the relative efficacy of antipsychotics for the treatment of positive and negative symptoms in early-onset schizophrenia, CNS Drugs, 30, 27, 10.1007/s40263-015-0308-1 Herbener, 2021, Course and symptom and functional correlates of passivity symptoms in schizophrenia: an 18-year multi-follow-up longitudinal study, Psychol. Med., 51, 503, 10.1017/S0033291719003428 Hopko, 2013, Behavioral activation and problem-solving therapy for depressed breast cancer patients: preliminary support for decreased suicidal ideation, Behav. Modif., 37, 747, 10.1177/0145445513501512 Jameel, 2020, Observed social support and willingness for the treatment of patients with schizophrenia, Psychol. Res. Behav. Manag., 13, 193, 10.2147/PRBM.S243722 Jana, 2014, Empowerment and its associations in schizophrenia: a cross-sectional study, Community Ment. Health J., 50, 697, 10.1007/s10597-014-9729-4 Janssen, 2021, How does behavioural activation work? A systematic review of the evidence on potential mediators, Psychother. Psychosom., 90, 85, 10.1159/000509820 Jauhar, 2014, Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias, Br. J. Psychiatry, 204, 20, 10.1192/bjp.bp.112.116285 Kim, 2015, Estimation of K-WAIS-IV premorbid intelligence in South Korea: development of the KPIE-IV, Clin. Neuropsychol., 29, 19, 10.1080/13854046.2015.1072248 Kirkpatrick, 2011, The brief negative symptom scale: psychometric properties, Schizophr. Bull., 37, 300, 10.1093/schbul/sbq059 Kring, 2014, The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs, Eur. Neuropsychopharmacol., 24, 725, 10.1016/j.euroneuro.2013.06.007 Kumari, 2017, An assessment of five (PANSS, SAPS, SANS, NSA-16, CGI-SCH) commonly used symptoms rating scales in schizophrenia and comparison to newer scales (CAINS, BNSS), J. Addict Res. Ther., 8, 324, 10.4172/2155-6105.1000324 Lasserson, 2022, Starting a review Lejuez, 2001, A brief behavioral activation treatment for depression: treatment manual, Behav. Modification, 25, 255, 10.1177/0145445501252005 Lutgens, 2017, Psychological and psychosocial interventions for negative symptoms in psychosis: systematic review and meta-analysis, Br. J. Psychiatry, 210, 324, 10.1192/bjp.bp.116.197103 Mairs, 2011, Development and pilot investigation of behavioral activation for negative symptoms, Behav. Modif., 35, 486, 10.1177/0145445511411706 Mairs, 2013, Psychosocial interventions for the negative symptoms of psychosis, Mental Health Practice, 16, 10.7748/mhp2013.02.16.5.19.s9539 Martell, 2010 Mortimer, 2007, Symptom rating scales and outcome in schizophrenia, Br. J. Psychiatry Suppl., 50, s7, 10.1192/bjp.191.50.s7 Mosolov, 2022, Primary and secondary negative symptoms in schizophrenia, Front. Psychiatry, 12, 10.3389/fpsyt.2021.766692 Mucci, 2015, The brief negative symptom scale (BNSS): independent validation in a large sample of Italian patients with schizophrenia, Eur. Psychiatry, 30, 641, 10.1016/j.eurpsy.2015.01.014 2021 National Institute for Health and Care Excellence (NICE). Psychosis and schizophrenia in adults: prevention and management: clinical guideline [CG178]. 2014. Ö, 2022, An analysis of the relationship between social support levels and treatment compliance of individuals diagnosed with schizophrenia, Perspect. Psychiatr. Care, 58, 578, 10.1111/ppc.12813 Porter, 2022, Reliability of the Calgary depression scale for schizophrenia: a meta-analysis, Schizophr. Res., 240, 32, 10.1016/j.schres.2021.11.040 Richards, 2010, Behavioural activation, Oxford Guide to Low Intensity CBT Interventions, 141, 50 Richards, 2016, Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial, Lancet, 388, 871, 10.1016/S0140-6736(16)31140-0 Riehle, 2020, Efficacy of psychological treatments for patients with schizophrenia and relevant negative symptoms: a meta-analysis, Clin. Psychol. Europe, 2, 1, 10.32872/cpe.v2i3.2899 Roth, 2013 Sabe, 2021, Antipsychotics for negative and positive symptoms of schizophrenia: dose-response meta-analysis of randomized controlled acute phase trials, NPJ Schizophr, 7, 43, 10.1038/s41537-021-00171-2 Schultz, 2007, Schizophrenia: a review, Am. Fam. Physician, 75, 1821 Selten, 1993, The subjective experience of negative symptoms: a self-rating scale, Compr. Psychiatry, 34, 192, 10.1016/0010-440X(93)90047-8 Staring, 2013, Cognitive behavioral therapy for negative symptoms (CBT-n) in psychotic disorders: a pilot study, J. Behav. Ther. Exp. Psychiatry, 44, 300, 10.1016/j.jbtep.2013.01.004 Sterne, 2016, ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions, BMJ, 355, i4919, 10.1136/bmj.i4919 Sterne, 2019, RoB 2: a revised tool for assessing risk of bias in randomised trials, BMJ, 366, l4898, 10.1136/bmj.l4898 2020 2013 Thomas, 2015, What's really wrong with cognitive behavioral therapy for psychosis?, Front. Psychol., 6, 323, 10.3389/fpsyg.2015.00323 Uphoff, 2020, Behavioural activation therapy for depression in adults with non-communicable diseases, Cochrane Database of Systematic Rev. van Genugten, 2021, Examining the theoretical framework of behavioral activation for major depressive disorder: smartphone-based ecological momentary assessment study, JMIR Ment. Health, 8, e32007, 10.2196/32007 Velthorst, 2015, Adapted cognitive–behavioural therapy required for targeting negative symptoms in schizophrenia: meta-analysis and meta-regression, Psychol. Med., 45, 453, 10.1017/S0033291714001147 2022 Walsh, 2022, Use of behavioural activation to manage pain: a systematic scoping review, BMJ Open, 12, 10.1136/bmjopen-2021-056404